ArticleJAC-antimicrobial resistance2026
Antibacterial prescribing for acute upper respiratory infections in outpatients in Finland, 2017-2021: a Finnish registry study.
Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antibiotic use is the main driver of antimicrobial resistance and adverse events. The aim of our study was to investigate the magnitude of prescribing antibacterials to outpatients with an acute upper respiratory infection (AURI) in Finland. Materials and methods: For the period 2017-2021, we linked data on antibacterial prescriptions (ATC group J01) from the Finnish Social Insurance Institution with disease data from Primary Care Outpatient Treatment Register and excluded diagnoses for which antibacterial treatment is indicated. We calculated the percentage of visits associated with at least one antibacterial prescription and performed univariate and multivariate logistic regression to assess the effect of year, demographic factors, AURI and selected underlying conditions. Results: Overall, 9% of all outpatient AURI diagnoses, most of which are of viral origin, were prescribed antibacterials in the public healthcare sector. This proportion decreased from 11% in 2017 to 6% in 2021 and increased with age. Women were slightly more likely to obtain a prescription than men (adjusted probability 1.09; 95%CI 1.08-1.11). Chronic pulmonary disease was associated with increased prescribing for AURIs in the multivariate analysis (adjusted probability 1.93; 95%CI 1.84-2.03), and acute tonsillitis had the highest likelihood of antibacterial prescribing compared with other AURIs (adjusted probability 14.70; 95%CI 13.41-16.12). Conclusions: Our research indicates that despite previous antimicrobial stewardship efforts, prescribing antibacterials for non-bacterial infections is still common in Finland. Nonetheless, the percentage of inappropriate prescribing decreased over time. Prescribing habits seem to be influenced by patient demographics and underlying chronic illnesses.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.